N-desMethyl EnzalutaMide (N-desmethyl MDV 3100) is the active metabolite of Enzalutamide, which is an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer.
[1] Sternberg CN. et al. Future Oncol. 2019 May;15(13):1437-1457.
















